Dr. Lal Path Labs Ltd. CC-Feb26.pdf · 2026-01-30
Sir, basically my question was the molecular diagnostic players like 3B BlackBio or Mylab, Molbio, they are coming into the industry, like Molbio filed their IPO, DRHP. Basically, are they a competition or are they a supplier to us for kits? And how is that molecular diagnostic industry doing? Can you give a color on that?
Basically, can you give the reasons why that side of portfolio is doing well and such extensive tests are taking market share from this simple testing?